Peptonic Medical AB (publ) announced that it has received its first order in Central America from Windsor Pharmaceuticals. The order from Windsor Pharmaceuticals is for Peptonic's vaginal self- tests VagiVital AL Sense, for detecting amniotic fluid leakage during pregnancy, and VagiVital VS Sense Pro for diagnosing bacterial vaginosis. Both products are aimed at professional users such as midwives and gynecologists.

The initial order includes ten thousand units of each product to be used for training and sales to healthcare facilities. The products will be delivered during fourth quarter. The order from Windsor Pharmaceutical's is made under the distribution agreement signed in early 2023 which runs for four years, with a possibility of extension.

Windsor Pharmaceuticals will sell the products under its own brand Amniotest. VagiVital VS is a clinically proven self-test that diagnoses symptoms of bacterial vaginosis and vaginal yeast infections with 92% accuracy. The test is performed on vaginal fluid and indicates the result within 30 seconds.

VagiVital AL is a clinically proven self- test with 97% accuracy that distinguishes amniotic fluid leakage fromurine leakage. The self-test consists of a pad with a patented biofilm on its surface where a result by color change is indicated 15 minutes after the pad has become moist. The only alternative to self-testing is a full-fledged gynecological examination.